In developed countries, increased survival rates are due to improved access to early diagnosis and effective treatments (including new adjuvant drugs), and less aggressive surgeries.3
The suboptimal OS rates in South Africa and other countries in the sub-Saharan region are attributed to factors such as advanced stage at diagnosis, aggressive tumour biology, elevated rates of HIV, and challenges in accessing optimal treatment.4
Who is at risk of BCa?
Non-modifiable risk factors include BRAC type 1 or BRAC type 2 mutations,...
